| Document |
Document Title |
|
WO/2018/015797A1 |
An object of the present invention is to provide a benzylamide compound or a salt thereof that controls a mite. The present invention provides a benzylamide compound represented by Formula (1): or a salt thereof, wherein R1 represents C1...
|
|
WO/2018/015852A1 |
An object of the present invention is to provide a benzylamide compound or a salt thereof that controls a mite. The present invention provides a benzylamide compound represented by Formula (1): or a salt thereof, wherein R1 represents C1...
|
|
WO/2018/003059A1 |
Provided is a method for preparing a polythiol compound, the method comprising: step 1 for reacting 2-mercaptoethanol, which has a water content of 3000 ppm or less on a mass basis, with epihalohydrin to obtain a halide represented by fo...
|
|
WO/2017/221620A1 |
Provided are: a curable composition which has excellent light exposure sensitivity and enables the achievement of a cured film that exhibits excellent adhesion to a supporting body; a cured film; a color filter; a light-blocking film; a ...
|
|
WO/2017/206703A1 |
A methionine new crystal form I, the crystal form II having diffraction peaks at 21.751±0.2°, 22.168±0.2°, 21.186±0.2°, 25.426±0.2°, 18.395±0.2°, and 32.879±0.2° at the diffraction angle 2θ. The methionine crystal form I of ...
|
|
WO/2017/206704A1 |
A methionine new crystal form II, the crystal form II having diffraction peaks at 22.304±0.2°, 33.757±0.2°, 45.674±0.2°, 28.104±0.2°, 18.615±0.2°, and 42.739±0.2° at the diffraction angle 2θ. The methionine crystal form II o...
|
|
WO/2017/206801A1 |
Disclosed are a class of diarylsulfide derivatives, a preparation method therefor, and the use thereof as a serotonin transporter-targeted imaging agent, belonging to the field of radiopharmaceutical chemistry. The diarylsulfide derivati...
|
|
WO/2017/202266A1 |
The present invention relates to a 2-amino-3-substituted mercaptopropionate derivative, a preparation method therefor and a use thereof. The 2-amino-3-substituted mercaptopropionate derivative according to the present invention has a str...
|
|
WO/2017/195149A1 |
Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
|
|
WO/2017/191196A1 |
There is provided a method of producing a method of producing methionine, the method comprising - contacting vinylglycine or derivatives thereof with at least one free radical methyl mercaptanin a reaction medium.
|
|
WO/2017/191195A1 |
There is provided a method of producing at least one unsaturated amino acid from at least one amino acid comprising at least two carbonyl groups, the method comprising (a) contacting a recombinant microbial cell with a medium comprising ...
|
|
WO/2017/188297A1 |
Provided is a resist composition that improves acid generation efficiency and is used to produce a photoresist having high sensitivity, high resolution, and high LWR properties. The present invention relates to a compound represented by ...
|
|
WO/2017/187859A1 |
The present invention is a compound represented by formula (1), a liquid crystal composition containing the compound, and a liquid crystal display element including the composition. In the formula: R is a C1-15 alkyl or the like; ring A1...
|
|
WO/2017/169819A1 |
A black photosensitive resin composition which contains: a photopolymerization initiator composition (A) that contains 1-99 parts by mass of the component (A-1) described below and 1-99 parts by mass of the component (A-2) described belo...
|
|
WO/2017/170952A1 |
The present invention relates to: a novel compound that is useful as a ligand in a variety of catalytic organic synthetic reactions; a method for easily and efficiently producing said novel compound; a synthetic intermediate of said nove...
|
|
WO/2017/162122A1 |
Disclosed herein are novel compounds and uses thereof. The present compounds may suppress the activity of farnesyl transferase and thus, may act as modulators of immune cells; therefor, they are useful for the development of a medicament...
|
|
WO/2017/159552A1 |
A high-purity polyfunctional thiol compound is obtained by a method for producing a polyfunctional thiol compound, the method including a step for reacting a compound represented by general formula (11) and a compound represented by HN(R...
|
|
WO/2017/153235A1 |
The invention relates to novel substituted N-cyclo-3-aryl-1-naphthamide derivatives, to methods for producing same, to the use thereof, either alone or in combination, for the treatment and/or prevention of diseases, and to their use for...
|
|
WO/2017/152539A1 |
Provided are a 4-sulfur pentafluoride phenol compound and a preparation method therefor, and a preparation method for a sulfur pentafluoride substituted benzopyran compound. According to the present invention, sulfur pentafluoride salicy...
|
|
WO/2017/155288A1 |
The present invention relates to a polyethylene glycol derivative and use thereof.
|
|
WO/2017/150478A1 |
[Problem] To provide an industrially preferred method for producing a sulfoxide derivative. [Solution] A method for producing a sulfoxide derivative represented by general formula (1), the method being characterized in that a sulfide der...
|
|
WO/2017/140733A1 |
A compound of formula (I) wherein R1, R2, R3 and R4 can be independently selected from H or Me, n = 0, 1, the dotted lines are indicating single bonds, or in case n = 0 an isolated double bond at position 3', or in case n = 1 an isolated...
|
|
WO/2017/140665A1 |
The present invention relates to a method for preparing 3-methylthiopropionaldehyde by reacting methyl mercaptan with acrolein, in which deviations in the stoichiometry of methyl mercaptan to acrolein in the reaction to give 3-methylthio...
|
|
WO/2017/134190A1 |
Herein is reported a deep eutectic solvent consisting of (2-hydroxyethyl) trimethyl ammonium chloride and dithiothreitol in a molar ratio of from 1:2 to 1:3 and of from 0 % to 10 % co-solvent.
|
|
WO/2017/125673A1 |
The invention relates to a method for preparing a compound (I) or one of the salts thereof, and the uses of said method, R1OOC-C(=X)-CHR2 R3 (I), wherein X is selected among O; N-R', wherein R' is H or a C1-C6 alkyl; and N-OR'' wherein R...
|
|
WO/2017/122822A1 |
The present invention addresses the problem of providing an industrially advantageous method for producing an optically active amidocarboxylic acid derivative, which is an important intermediate of a depsipeptide compound expected to be ...
|
|
WO/2017/109178A1 |
A subject of the present invention is the use of a compound having the general formula (I): (I) wherein V, W, X4, X5, X6, X7, X'4, X'5, X'6, X'7, Y, Y', R3, R'3, R4 and R'4 are as defined in any one of claims 1 to 11, for the detection, ...
|
|
WO/2017/112574A1 |
Pharmaceutical compositions for treating, mitigating or preventing kidney stone disease, bladder stone disease or ureter stone disease are described, the compositions comprising a reducing agent capable of undergoing thiol-disulfide exch...
|
|
WO/2017/096450A1 |
The present invention describes new derivatives of S-allyicysteine with antioxidant and antiaging activity. Said derivatives can be used alone or in a combined formulation with other compounds with known activity.
|
|
WO/2017/100602A1 |
Disclosed herein are methods of preparing an aminimide. An epoxy compound is reacted with a hydrazine compound comprising a trivalent nitrogen, and an anhydride functional material or a cyclic compound containing a carbonyl group and at ...
|
|
WO/2017/097872A1 |
The invention relates to compounds of general formula (I), where the groups R1 and R2 independently have the meaning (CH2)n , n being an integer between 1 and 10, and R3 and R4 independently represent an alkyl group containing 1 to 10 C ...
|
|
WO/2017/095873A1 |
A process includes reacting, in a reactor having a fixed bed containing a solid catalyst which contains a heterogeneous ion exchange resin, hydrogen sulfide and ethylene oxide in the presence of the solid catalyst to yield a reaction pro...
|
|
WO/2017/093172A1 |
Disclosed is a method for producing 2-alkyl-4-trifluoromethyl-3-alkyl sulfonyl benzoic acids of formula (I). In said formula, the substituents represent groups such as alkyl and substituted phenyl.
|
|
WO/2017/093732A1 |
The invention relates to lipid compounds of formula (I) and their pharmaceutically acceptable salts for the prevention and/or treatment of ophthalmic disorders such as retinal degenerative disorders and ocular inflammatory diseases: (I) ...
|
|
WO/2017/081122A1 |
Process for treating keratin fibres with a cationic disulfide compound The invention relates to a process for treating keratin fibres, in particular human keratin fibres such as the hair, comprising: (i) a step of applying a compound (I)...
|
|
WO/2017/083243A1 |
Thioether-substituted phenols that are the reaction product of a thioether-substituted alcohol or thioether-substituted amine and a phenol with at least one pendant acyl group and have a ratio of sulfur groups to phenol groups of at leas...
|
|
WO/2017/072343A1 |
The invention relates to a compound that can be produced according to a method comprising at least one step of polymerisation of at least one monomer of formula (I), said step of polymerisation being carried out in the presence of a cata...
|
|
WO/2017/067500A1 |
The invention relates to the field of mite killers, and specifically, to a biphenyl compound and application thereof. The structure is expressed by formula I, and each substituent in the formula is defined in the specification. The formu...
|
|
WO/2017/070482A2 |
PPSMA binding scaffolds with radioiodinated, radiobrominated and radioastatinated labeled prosthetic groups are disclosed. Pharmaceutical compositions and methods of treating PSMA expressing cells or tumors also are disclosed.
|
|
WO/2017/064250A1 |
The present invention relates to an industrial process for the preparation of (5S,10S)-10- benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trith
ia-12-azahenicosan-5-aminium (E)-3-carboxyacrylate salt of following formula (I) : wh...
|
|
WO/2017/050314A1 |
The invention relates to a compound having the chemical formula (I), wherein R1 represents the amino acids 1-120 of beta-lactoglobulin and R2 the amino acids 122-162 of beta-lactoglobulin from cow's milk. The invention further relates to...
|
|
WO/2017/053360A1 |
Histone deacetylases inhibitors (HDACIs) and compositions containing the same are disclosed. Methods of treating diseases and conditions wherein inhibition of HDAC provides a benefit, like a cancer, a neurodegenerative disorder, a periph...
|
|
WO/2017/047572A1 |
A heat-sensitive recording material obtained by forming a heat-sensitive recording layer, which contains a basic dye and a developer, on a supporting body. The developer is composed of at least one N-substituted amino acid derivative rep...
|
|
WO/2017/029377A1 |
The present invention provides a process for preparation of Vortioxetine hydrobromide (I). The present invention also relates to the novel intermediate and its use in preparation of vortioxetine hydrobromide (I).
|
|
WO/2017/030950A1 |
A photoactivatable fouling-resistant copolymer composed of a photoactivatable monomer and a hydrophilic monomer is disclosed. The photoactivatable monomer includes an aryl ketone derivative having one or more polar groups or alkyl groups.
|
|
WO/2017/026298A1 |
The present invention addresses the problem of providing a compound which can exhibit an excellent controlling effect against harmful arthropods. The problem can be solved by an oxalyl amide compound represented by formula (I) [wherein G...
|
|
WO/2017/024703A1 |
The present invention provides an aromatic amine compound comprising a structure of formula (I). The compound provided according to the invention has luminous efficacy, which will result in, when in a condition of a current density of 20...
|
|
WO/2017/025802A1 |
Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
|
|
WO/2017/017104A1 |
The invention relates to ceramide dimers consisting of two ceramides, in which the amino alcohols are linked in an amide-like manner by means of a dicarboxylic acid. The dicarboxylic acids obtain at least one sulphur atom in the chain. T...
|
|
WO/2017/018489A1 |
Provided are: a fluorine-containing compound that can obtain a cured product having excellent heat resistance, a superior ability to be released from molds, and a high Abbe number; a curable composition that includes the compound; and a ...
|
